dm+d
420155008
Articles
Treating acute hypokalaemia in adults
14 August 2024
Medicine Compliance Aid Stability
Sando-KAlturix Limited
Alturix Limited
Sando-K
Tablets efferverscent 12mmol K+
R1 · Red 1Stability data indicates that the drug is not suitable for CAs.
Unsuitable
Contains dessicant in pack.
23 November 2022
Slow-KAlturix Limited
Alturix Limited
Slow-K
Tablets m/r 8mmol K+ (600MG)
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Airtight container
Keep container tightly closed.
23 November 2022
Lactation Safety Information
Oral / Parenteral
Oral / Parenteral
31 July 2020